$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

$eltp Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000114420413061851 Filed on November 14, 2013

Income Statement

Concept	2013 Q3	2012 Q3
Revenue	$1.159M	$634.5K
YoY Change	82.66%
Cost Of Revenue	$617.0K	$479.6K
YoY Change	28.64%
Gross Profit	$542.0K	$154.9K
YoY Change	249.93%
Gross Profit Margin	46.76%	24.41%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$854.8K	$228.5K
YoY Change	274.12%
% of Gross Profit	157.71%	147.51%
Depreciation & Amortization	$110.0K	$120.0K
YoY Change	-8.33%	0.0%
% of Gross Profit	20.3%	77.48%
Operating Expenses	$1.229M	$670.2K
YoY Change	83.39%
Operating Profit	-$687.0K	-$515.3K
YoY Change	33.33%
Interest Expense	$255.9K	$61.25K
YoY Change	317.89%
% of Operating Profit
Other Income/Expense, Net	-$6.887M	$1.566M
YoY Change	-539.73%
Pretax Income	-$9.635M	$1.051M
YoY Change	-1016.83%
Income Tax	$2.000K
% Of Pretax Income
Net Earnings	-$9.638M	$1.050M
YoY Change	-1017.98%
Net Earnings / Revenue	-831.58%	165.47%
Basic Earnings Per Share	-$0.02	$0.00
Diluted Earnings Per Share	-$0.02	$0.00
COMMON SHARES
Basic Shares Outstanding	422.0M shares	348.3M shares
Diluted Shares Outstanding	422.0M shares	505.8M shares

Balance Sheet

Concept	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$770.0K	$210.0K
YoY Change	266.67%	-84.33%
Cash & Equivalents	$766.2K	$207.3K
Short-Term Investments
Other Short-Term Assets	$160.0K	$110.0K
YoY Change	45.45%	10.0%
Inventory	$1.720M	$480.0K
Prepaid Expenses
Receivables	$636.0K	$560.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.279M	$1.360M
YoY Change	141.08%	-34.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.940M	$4.170M
YoY Change	-5.51%	-1.65%
Goodwill
YoY Change
Intangibles	$6.314M
YoY Change
Long-Term Investments	$3.340M	$3.340M
YoY Change	0.0%	0.0%
Other Assets	$540.0K	$530.0K
YoY Change	1.89%	-5.36%
Total Long-Term Assets	$14.13M	$8.710M
YoY Change	62.26%	-0.46%
TOTAL ASSETS
Total Short-Term Assets	$3.279M	$1.360M
Total Long-Term Assets	$14.13M	$8.710M
Total Assets	$17.41M	$10.07M
YoY Change	72.91%	-7.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.930M	$1.130M
YoY Change	70.8%	20.21%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$6.380M	$0.00
YoY Change
Long-Term Debt Due	$3.390M	$3.590M
YoY Change	-5.57%	5.59%
Total Short-Term Liabilities	$11.72M	$4.760M
YoY Change	146.3%	6.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$96.08K	$27.11M
YoY Change	-99.65%	-9.78%
Total Long-Term Liabilities	$11.54M	$27.11M
YoY Change	-57.43%	-9.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.72M	$4.760M
Total Long-Term Liabilities	$11.54M	$27.11M
Total Liabilities	$23.26M	$31.88M
YoY Change	-27.03%	-7.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$137.1M
YoY Change
Common Stock	$131.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$306.8K
YoY Change
Treasury Stock Shares	100.0K shares
Shareholders Equity	-$5.852M	-$21.80M
YoY Change
Total Liabilities & Shareholders Equity	$17.41M	$10.07M
YoY Change	72.91%	-7.02%

Cashflow Statement

Concept	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$9.638M	$1.050M
YoY Change	-1017.98%
Depreciation, Depletion And Amortization	$110.0K	$120.0K
YoY Change	-8.33%	0.0%
Cash From Operating Activities	-$920.0K	-$840.0K
YoY Change	9.52%	78.72%
INVESTING ACTIVITIES
Capital Expenditures	-$90.00K	-$100.0K
YoY Change	-10.0%	233.33%
Acquisitions
YoY Change
Other Investing Activities	$50.00K	$40.00K
YoY Change	25.0%	-180.0%
Cash From Investing Activities	-$50.00K	-$60.00K
YoY Change	-16.67%	-25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.510M	630.0K
YoY Change	139.68%	425.0%
NET CHANGE
Cash From Operating Activities	-920.0K	-840.0K
Cash From Investing Activities	-50.00K	-60.00K
Cash From Financing Activities	1.510M	630.0K
Net Change In Cash	540.0K	-270.0K
YoY Change	-300.0%	-37.21%
FREE CASH FLOW
Cash From Operating Activities	-$920.0K	-$840.0K
Capital Expenditures	-$90.00K	-$100.0K
Free Cash Flow	-$830.0K	-$740.0K
YoY Change	12.16%	68.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Trading Symbol TradingSymbol	ELTP
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	507937469	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001053369
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2013Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2013Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2013Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	93338	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5283619	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5068522	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2013Q2	dei	Document Type DocumentType	10-Q
	dei	Entity Registrant Name EntityRegistrantName	ELITE PHARMACEUTICALS INC /NV/
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2013Q3	eltp	Accumulated Amortization Eda Bond Offering Costs AccumulatedAmortizationEdaBondOfferingCosts	114608	USD
CY2013Q1	eltp	Accumulated Amortization Eda Bond Offering Costs AccumulatedAmortizationEdaBondOfferingCosts	107519	USD
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	690000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	690000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	494811263	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	374493959	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	374393959	shares
CY2013Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2013Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2013Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4219292	USD
CY2013Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	766201	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	369023	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	635959	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	665154	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	1719673	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	1358146	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	156916	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	151051	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	3278749	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	2543374	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3940211	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4028943	USD
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6314004	USD
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	694426	USD
CY2013Q3	us-gaap	Cost Method Investments CostMethodInvestments	3329322	USD
CY2013Q1	us-gaap	Cost Method Investments CostMethodInvestments	3329322	USD
CY2013Q3	us-gaap	Security Deposit SecurityDeposit	14314	USD
CY2013Q1	us-gaap	Security Deposit SecurityDeposit	14314	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	295462	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	267820	USD
CY2013Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	239845	USD
CY2013Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	246934	USD
CY2013Q3	eltp	Assets Noncurrent Excluding Property Plant And Equipment And Intangible Assets AssetsNoncurrentExcludingPropertyPlantAndEquipmentAndIntangibleAssets	3878943	USD
CY2013Q1	eltp	Assets Noncurrent Excluding Property Plant And Equipment And Intangible Assets AssetsNoncurrentExcludingPropertyPlantAndEquipmentAndIntangibleAssets	3858390	USD
CY2013Q3	us-gaap	Assets Assets	17411907	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1213072	USD
	us-gaap	Cost Of Revenue CostOfRevenue	933995	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	154886	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	479631	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1195647	USD
CY2013Q3	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	-6129579	USD
CY2012Q3	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	2093653	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	245399	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67370	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	1228842	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	670154	USD
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	494711263	shares
CY2013Q1	eltp	Short Term Loans And Current Portion Of Long Term Debt ShortTermLoansAndCurrentPortionOfLongTermDebt	6296	USD
CY2013Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1925375	USD
CY2013Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	18937	USD
	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	845716	USD
CY2013Q1	us-gaap	Assets Assets	11125133	USD
CY2013Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	3385000	USD
CY2013Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	3385000	USD
CY2013Q3	eltp	Short Term Loans And Current Portion Of Long Term Debt ShortTermLoansAndCurrentPortionOfLongTermDebt	2916	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17411907	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11125133	USD
CY2013Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5780708	USD
CY2013Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2013Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	600000	USD
CY2013Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	600000	USD
CY2013Q3	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	921347	USD
CY2012Q3	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	466020	USD
	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	1464780	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	131106847	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119690336	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137147220	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128431375	USD
CY2013Q3	us-gaap	Treasury Stock Value TreasuryStockValue	306841	USD
CY2013Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-5852402	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	-8673385	USD
CY2013Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1325126	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	USD
CY2013Q3	eltp	Preferred Share Derivative Interest Payable PreferredShareDerivativeInterestPayable	16365	USD
CY2013Q1	eltp	Preferred Share Derivative Interest Payable PreferredShareDerivativeInterestPayable	27500	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11723697	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5357255	USD
CY2013Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	145556	USD
CY2013Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	152223	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	96078	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	91571	USD
CY2013Q3	eltp	Derivative Liability Preferred Shares DerivativeLiabilityPreferredShares	203008	USD
CY2013Q1	eltp	Derivative Liability Preferred Shares DerivativeLiabilityPreferredShares	6334621	USD
CY2013Q3	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	11095970	USD
CY2013Q1	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	7862848	USD
CY2013Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11540612	USD
CY2013Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14441263	USD
CY2013Q3	us-gaap	Liabilities Liabilities	23264309	USD
CY2013Q1	us-gaap	Liabilities Liabilities	19798518	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	494812	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	374495	USD
CY2013Q3	us-gaap	Royalty Revenue RoyaltyRevenue	231578	USD
CY2012Q3	us-gaap	Royalty Revenue RoyaltyRevenue	154168	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	404833	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	282663	USD
CY2013Q3	us-gaap	Contracts Revenue ContractsRevenue	5972	USD
CY2012Q3	us-gaap	Contracts Revenue ContractsRevenue	14329	USD
	us-gaap	Contracts Revenue ContractsRevenue	10972	USD
	us-gaap	Contracts Revenue ContractsRevenue	84693	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1158897	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	634517	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1880585	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	616635	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	542262	USD
	us-gaap	Gross Profit GrossProfit	684938	USD
	us-gaap	Gross Profit GrossProfit	279077	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	854777	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	228475	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1424268	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	425357	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	272561	USD
CY2013Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	82567	USD
CY2012Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25372	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	4809	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	401174	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	649018	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	766135	USD
CY2012Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	15133	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	28424	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	21246	USD
	us-gaap	Operating Expenses OperatingExpenses	2347109	USD
	us-gaap	Operating Expenses OperatingExpenses	1280108	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-686580	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-515268	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1662171	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1001031	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	255945	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	61247	USD
	us-gaap	Interest Expense InterestExpense	330723	USD
	us-gaap	Interest Expense InterestExpense	119784	USD
	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	-3233122	USD
	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	-2995081	USD
CY2013Q3	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	-2565495	USD
CY2012Q3	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	-187383	USD
	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	-3466332	USD
	eltp	Change In Fair Value Of Preferred Share Derivatives ChangeInFairValueOfPreferredShareDerivatives	-4830866	USD
CY2013Q3	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	17476	USD
CY2012Q3	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	28823	USD
	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	41060	USD
	eltp	Interest Expense Preferred Share Derivatives InterestExpensePreferredShareDerivatives	83901	USD
CY2013Q3	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	0	USD
CY2012Q3	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	250000	USD
	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	0	USD
	eltp	Discount In Series E Issuance Attributable To Beneficial Conversion Features DiscountInSeriesEIssuanceAttributableToBeneficialConversionFeatures	437500	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8948664	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1566200	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7051406	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8467132	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9635244	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1050932	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8713577	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9468163	USD
CY2013Q3	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	2269	USD
CY2012Q3	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	1023	USD
	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	2269	USD
	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	4023	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-9637513	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	1049909	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8715846	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9472186	USD
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	421991654	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	348298807	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	405073773	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	342712859	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	421991654	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	505759554	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	405073773	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	342712859	shares
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19831	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19831	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1900000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	52196	USD
	eltp	Conversion Of Series B Series C And Series E Preferred Shares Into Common Shares Value ConversionOfSeriesBSeriesCAndSeriesEPreferredSharesIntoCommonSharesValue	9597945	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28424	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	47987	USD
	eltp	Stock Issued During Period Value Payment Of Directors Fees StockIssuedDuringPeriodValuePaymentOfDirectorsFees	0	USD
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	6250	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	222299	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	236143	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	52196	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	126106	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	3799	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	708	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	667	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29195	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	166096	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	361527	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	175853	USD
	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	5865	USD
	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	-15592	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	442119	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-39828	USD
	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	-6667	USD
	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	-6669	USD
	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	-11135	USD
	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	-42206	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1284704	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1139828	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	120396	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	96156	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	6082	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	20082	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22261	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	23315	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	27642	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-6554	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-176381	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-132999	USD
	eltp	Proceeds From Issuance Of Series E Convertible Preferred Stock ProceedsFromIssuanceOfSeriesEConvertiblePreferredStock	0	USD
	eltp	Proceeds From Issuance Of Series E Convertible Preferred Stock ProceedsFromIssuanceOfSeriesEConvertiblePreferredStock	437500	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1900000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3381	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	47987	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9856	USD
	eltp	Interest Expense Non Cash InterestExpenseNonCash	183391	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	5597317	USD
	us-gaap	Notes Issued1 NotesIssued1	5597317	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1858263	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	811763	USD
	eltp	Commitment Shares Issued CommitmentSharesIssued	260538	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	9597945	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6250	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	187500	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	200000	USD
	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	154750	USD
	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	95000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	397178	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-461064	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	668407	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	207343	USD
	us-gaap	Interest Paid InterestPaid	115826	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	4023	USD
CY2013Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	910187	USD
CY2013Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	774758	USD
CY2013Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	809486	USD
CY2013Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	676726	USD
CY2013Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2013Q2	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	18498	USD
CY2013Q3	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	5601082	USD
	eltp	Finite Lived Intangible Assets Acquired During Period FiniteLivedIntangibleAssetsAcquiredDuringPeriod	5619580	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2013Q3	eltp	Bond Issue Costs BondIssueCosts	354453	USD
CY2013Q1	eltp	Accumulated Amortization Of Bond AccumulatedAmortizationOfBond	107519	USD
CY2013Q3	us-gaap	Deferred Revenue DeferredRevenue	158889	USD
CY2013Q3	eltp	Accumulated Amortization Of Bond AccumulatedAmortizationOfBond	114608	USD
CY2013Q1	eltp	Unamortization Of Bond UnamortizationOfBond	246934	USD
CY2013Q3	eltp	Unamortization Of Bond UnamortizationOfBond	239845	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	415500	USD
CY2013Q1	eltp	Bond Issue Costs BondIssueCosts	354453	USD
CY2013Q1	eltp	Recognized Deferred Revenue RecognizedDeferredRevenue	34444	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	6667	USD
CY2013Q3	eltp	Payments Received In Advance PaymentsReceivedInAdvance	200000	USD
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	8575	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	182	shares
CY2013Q3	eltp	Preferred Stock Conversion Shares PreferredStockConversionShares	1638479	shares
CY2013Q3	eltp	Preferred Stock Closing Price PreferredStockClosingPrice	0.12
CY2013Q3	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	203008	USD
CY2013Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	6334621	USD
	eltp	Operating Lease Description OperatingLeaseDescription	initial term of 5 years and 6 months and the Company has the option to renew the lease for two additional terms, each of 5 years
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9637513	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1049909	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8715846	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9472186	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	83259	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	85344	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	87363	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	89112	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	90894	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	435972	USD
CY2013Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	22584	USD
CY2012Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	22584	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	45169	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	45169	USD
CY2013Q3	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	1899	USD
CY2012Q3	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	2403	USD
CY2013Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	68260	USD
CY2013Q2	us-gaap	Deferred Rent Credit DeferredRentCredit	70160	USD
CY2013Q3	us-gaap	Deferred Rent Credit DeferredRentCredit	72062	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2552332	shares
CY2013Q3	eltp	Share Based Compensation Arrangement By Share Based Payment Award Non Vested Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonVestedOptionsOutstandingNumber	4156668	shares
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1078733	USD
CY2012Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	157460747	shares
CY2013Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10000000	USD
CY2013Q3	eltp	Net Present Value Of Note NetPresentValueOfNote	5597317	USD
CY2013Q3	eltp	Finite Lived Intangible Assets Acquired Aggregate Cost FiniteLivedIntangibleAssetsAcquiredAggregateCost	5597317	USD

Files In Submission

Name	View Source	Status
0001144204-13-061851-index-headers.html	Edgar Link	pending
0001144204-13-061851-index.html	Edgar Link	pending
0001144204-13-061851.txt	Edgar Link	pending
0001144204-13-061851-xbrl.zip	Edgar Link	pending
eltp-20130930.xml	Edgar Link	completed
eltp-20130930.xsd	Edgar Link	pending
eltp-20130930_cal.xml	Edgar Link	unprocessable
eltp-20130930_def.xml	Edgar Link	unprocessable
eltp-20130930_lab.xml	Edgar Link	unprocessable
eltp-20130930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v359288_10q.htm	Edgar Link	pending
v359288_ex10-16.htm	Edgar Link	pending
v359288_ex10-17.htm	Edgar Link	pending
v359288_ex10-18.htm	Edgar Link	pending
v359288_ex31-1.htm	Edgar Link	pending
v359288_ex31-2.htm	Edgar Link	pending
v359288_ex32-1.htm	Edgar Link	pending
v359288_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2013 Q3 Form 10-Q Financial Statement

#000114420413061851 Filed on November 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2013 Q3 Form 10-Q Financial Statement

#000114420413061851 Filed on November 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp